Yohei Asano

472 total citations
67 papers, 261 citations indexed

About

Yohei Asano is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Yohei Asano has authored 67 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 19 papers in Rheumatology. Recurrent topics in Yohei Asano's work include Sarcoma Diagnosis and Treatment (27 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Cancer Research and Treatments (9 papers). Yohei Asano is often cited by papers focused on Sarcoma Diagnosis and Treatment (27 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Cancer Research and Treatments (9 papers). Yohei Asano collaborates with scholars based in Japan, United States and Philippines. Yohei Asano's co-authors include Akihiko Takeuchi, Kentaro Igarashi, Sei Morinaga, Katsuhiro Hayashi, Hiroyuki Tsuchiya, Shinji Miwa, Norio Yamamoto, Yoshihiro Araki, Hirotaka Yonezawa and Takashi Higuchi and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Orthopaedics and Related Research.

In The Last Decade

Yohei Asano

46 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohei Asano Japan 10 143 93 75 65 35 67 261
Wanlim Kim South Korea 11 155 1.1× 102 1.1× 63 0.8× 102 1.6× 18 0.5× 41 313
Manuel Niederhagen Germany 8 103 0.7× 39 0.4× 90 1.2× 142 2.2× 73 2.1× 18 336
Julia D. Visgauss United States 9 177 1.2× 53 0.6× 98 1.3× 95 1.5× 15 0.4× 29 261
Primo Andrea Daolio Italy 12 233 1.6× 93 1.0× 154 2.1× 121 1.9× 14 0.4× 25 410
Shervin V. Oskouei United States 10 194 1.4× 107 1.2× 95 1.3× 95 1.5× 8 0.2× 19 290
Matthias Sperl Austria 8 147 1.0× 97 1.0× 46 0.6× 117 1.8× 7 0.2× 12 312
Shunichi Toki Japan 11 139 1.0× 53 0.6× 70 0.9× 111 1.7× 7 0.2× 41 293
Narihito Kodama Japan 7 119 0.8× 59 0.6× 54 0.7× 157 2.4× 22 0.6× 16 305
Dorian Yarih García-Ortega Mexico 8 127 0.9× 83 0.9× 69 0.9× 40 0.6× 8 0.2× 37 215
Sarah E. Bosma Netherlands 10 175 1.2× 35 0.4× 79 1.1× 109 1.7× 15 0.4× 13 260

Countries citing papers authored by Yohei Asano

Since Specialization
Citations

This map shows the geographic impact of Yohei Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Asano more than expected).

Fields of papers citing papers by Yohei Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Asano. The network helps show where Yohei Asano may publish in the future.

Co-authorship network of co-authors of Yohei Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Asano. A scholar is included among the top collaborators of Yohei Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Asano. Yohei Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Asano, Yohei, Akihiko Takeuchi, Satoshi Kato, et al.. (2024). Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases. International Immunopharmacology. 136. 112276–112276. 4 indexed citations
3.
Asano, Yohei, Norio Yamamoto, Akihiko Takeuchi, et al.. (2024). Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases. Lung Cancer. 193. 107858–107858. 7 indexed citations
4.
Asano, Yohei, Norio Yamamoto, Satoru Demura, et al.. (2023). Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis. Cancer Medicine. 12(11). 12425–12437. 13 indexed citations
5.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2023). Graft Survivals after Reconstruction Using Tumor-Bearing Frozen Bone in the Extremities. Cancers. 15(15). 3926–3926. 2 indexed citations
6.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2023). Case Report: Unresectable pulmonary metastases of a giant cell tumor of bone treated with denosumab: a case report and review of literature. Frontiers in Oncology. 13. 1230074–1230074. 3 indexed citations
7.
8.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2022). A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy. Clinical Nuclear Medicine. 48(1). 25–34. 1 indexed citations
9.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2022). Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review. In Vivo. 36(6). 2899–2909. 4 indexed citations
10.
Yamamoto, Norio, Katsuhiro Hayashi, Akihiko Takeuchi, et al.. (2022). Clinical Outcomes of Soft Tissue Sarcoma around the Elbow Joint: A Retrospective Single Institution Study. Sarcoma. 2022. 1–8. 1 indexed citations
11.
Asano, Yohei, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2022). Clinical Outcomes of Limb-sparing Tumor Surgery With Vascular Reconstruction for Bone and Soft-tissue Tumors. Anticancer Research. 42(9). 4619–4626. 1 indexed citations
12.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma. Scientific Reports. 11(1). 1989–1989. 10 indexed citations
13.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma. Scientific Reports. 11(1). 8831–8831. 1 indexed citations
14.
15.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). Clinical outcomes of frozen autograft reconstruction for the treatment of primary bone sarcoma in adolescents and young adults. Scientific Reports. 11(1). 17291–17291. 12 indexed citations
16.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). A Radiological Scoring System for Differentiation between Enchondroma and Chondrosarcoma. Cancers. 13(14). 3558–3558. 9 indexed citations
17.
Miwa, Shinji, Takayuki Nojima, Hiroko Ikeda, et al.. (2021). Associations of PD-L1, PD-L2, and HLA class I expression with responses to immunotherapy in patients with advanced sarcoma: post hoc analysis of a phase 1/2 trial. Clinical & Translational Oncology. 23(8). 1620–1629. 3 indexed citations
18.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). Delayed Initiation of Treatment Is Associated With Metastasis of Malignant Bone Tumor. Anticancer Research. 41(6). 2993–2999. 5 indexed citations
19.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2020). Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors. International Journal of Clinical Oncology. 25(12). 2158–2165. 7 indexed citations
20.
Asano, Yohei, et al.. (1990). [A clinical study of associated bladder cancer in patients with renal pelvic and ureteral cancer].. PubMed. 36(10). 1141–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wanlim Kim Breakdown of academic impact, for papers by Manuel Niederhagen Breakdown of academic impact, for papers by Julia D. Visgauss Breakdown of academic impact, for papers by Primo Andrea Daolio Breakdown of academic impact, for papers by Shervin V. Oskouei Breakdown of academic impact, for papers by Matthias Sperl Breakdown of academic impact, for papers by Shunichi Toki Breakdown of academic impact, for papers by Narihito Kodama Breakdown of academic impact, for papers by Dorian Yarih García-Ortega Breakdown of academic impact, for papers by Sarah E. Bosma
Rankless by CCL
2026